News

February 19, 2019February 19, 2019

Having More Comorbidities Linked with Confusion After DBS in Parkinson’s Patients

News

Having a higher number of comorbidities is associated with postoperative confusion in Parkinson’s patients undergoing deep brain stimulation (DBS), according to a new study in Brazilian patients. The study, “Postoperative ... Read more

February 19, 2019February 19, 2019

Patient-Derived Neurons Show Promise as Model for Parkinson’s Research, Study Finds

News

Stem cell-derived neurons from patients with familial forms of Parkinson’s may be used as a valuable model to screen and develop novel therapies for this disease, according to a ... Read more

February 18, 2019February 18, 2019

Iowa City is Next Stop for Parkinson’s Foundation’s Team Training Program

News

The Parkinson’s Foundation is bringing Allied Team Training for Parkinson’s (ATTP), its signature professional education program, to Iowa City, Iowa, on March 27-30. The program is intended to help ... Read more

February 18, 2019February 18, 2019

MRI Technique Helps Distinguish Between Parkinson’s and Progressive Supranuclear Palsy, Study Reports

News

A specific magnetic resonance imaging (MRI) measure can accurately predict the development of eye movement abnormalities, helping to identify patients who develop progressive supranuclear palsy with parkinsonism (PSP-P) after an ... Read more

February 15, 2019February 18, 2019

ProMIS Neurosciences Develops Antibodies Targeting Toxic Forms of Alpha-Synuclein

News

ProMIS Neurosciences has identified several antibody candidates that specifically target the toxic forms of alpha-synuclein, a key component of Lewy bodies that underlie the development of Parkinson’s disease. In vitro (in the lab) ... Read more

February 15, 2019February 18, 2019

Behavioral, Metabolic Changes Linked to Sleep Restriction Could Foretell Parkinson’s, Animal Study Suggests

News

Chronic sleep restriction alters movement, worsens cognitive dysfunction and induces changes in the levels of several amino acids — the building blocks of proteins — and other markers in ... Read more

February 14, 2019February 14, 2019

L‐DOPA Treatment Prevents Age-related Iron Accumulation, Mouse Study Finds

News

Levodopa (L-DOPA) therapy is neuroprotective and prevents age-related iron accumulation in the substantia nigra, a brain region involved in Parkinson’s disease. The study with that finding, “L-DOPA modulates brain iron, dopaminergic ... Read more

February 13, 2019February 13, 2019

Vitamin A Supplement Fails to Protect or Treat Rats in Parkinson’s Disease Model, Study Says

News

Vitamin A, or retinol, given as an oral supplement did not prevent the loss of dopamine-producing neurons or lessen motor deficits in a rat model of Parkinson’s, a study reports. Results ... Read more

February 13, 2019February 14, 2019

Parkinson’s Foundation Will Gather Experts to Study Cannabis as Disease Therapy

News

These days, people with Parkinson’s disease tend to ask their doctors more questions about cannabis than any other subject; yet, few physicians have adequate answers for them. So says a ... Read more

February 12, 2019February 13, 2019

Gut-Brain Connection Issues are Critical to Understanding Parkinson’s, Review Contends

News

Upon breaking down two decades of research about how the gut affects the brain in Parkinson’s disease, a vision for studying the gut-brain connection for the next two decades has ... Read more

Pin It on Pinterest